TY - JOUR
T1 - Structural insights into HIV-1 Vif-APOBEC3F interaction
AU - Nakashima, Masaaki
AU - Ode, Hirotaka
AU - Kawamura, Takashi
AU - Kitamura, Shingo
AU - Naganawa, Yuriko
AU - Awazu, Hiroaki
AU - Tsuzuki, Shinya
AU - Matsuoka, Kazuhiro
AU - Nemoto, Michiko
AU - Hachiya, Atsuko
AU - Sugiura, Wataru
AU - Yokomaku, Yoshiyuki
AU - Watanabe, Nobuhisa
AU - Iwatani, Yasumasa
N1 - Funding Information:
This work was funded by the Japan Society for the Promotion of Science (JSPS) under grant 15J12567 (Masaaki Nakashima). This work was funded by JSPS under KAKENHI grant 15H04740 (Yasumasa Iwatani) and by the Japan Agency for Medical Research and Development (AMED) (Yasumasa Iwatani). This work was performed under the approval of the Photon Factory Program Advisory Committee (proposal no. 2012G642, 2014G559).
Publisher Copyright:
© 2015, American Society for Microbiology.
PY - 2016
Y1 - 2016
N2 - The HIV-1 Vif protein inactivates the cellular antiviral cytidine deaminase APOBEC3F (A3F) in virus-infected cells by specifically targeting it for proteasomal degradation. Several studies identified Vif sequence motifs involved in A3F interaction, whereas a Vif-binding A3F interface was proposed based on our analysis of highly similar APOBEC3C (A3C). However, the structural mechanism of specific Vif-A3F recognition is still poorly understood. Here we report structural features of interaction interfaces for both HIV-1 Vif and A3F molecules. Alanine-scanning analysis of Vif revealed that six residues located within the conserved Vif F1-, F2-, and F3-box motifs are essential for both A3C and A3F degradation, and an additional four residues are uniquely required for A3F degradation. Modeling of the Vif structure on an HIV-1 Vif crystal structure revealed that three discontinuous flexible loops of Vif F1-, F2-, and F3-box motifs sterically cluster to form a flexible A3F interaction interface, which represents hydrophobic and positively charged surfaces. We found that the basic Vif interface patch (R17, E171, and R173) involved in the interactions with A3C and A3F differs. Furthermore, our crystal structure determination and extensive mutational analysis of the A3F C-terminal domain demonstrated that the A3F interface includes a unique acidic stretch (L291, A292, R293, and E324) crucial for Vif interaction, suggesting additional electrostatic complementarity to the Vif interface compared with the A3C interface. Taken together, these findings provide structural insights into the A3F-Vif interaction mechanism, which will provide an important basis for development of novel anti-HIV-1 drugs using cellular cytidine deaminases.
AB - The HIV-1 Vif protein inactivates the cellular antiviral cytidine deaminase APOBEC3F (A3F) in virus-infected cells by specifically targeting it for proteasomal degradation. Several studies identified Vif sequence motifs involved in A3F interaction, whereas a Vif-binding A3F interface was proposed based on our analysis of highly similar APOBEC3C (A3C). However, the structural mechanism of specific Vif-A3F recognition is still poorly understood. Here we report structural features of interaction interfaces for both HIV-1 Vif and A3F molecules. Alanine-scanning analysis of Vif revealed that six residues located within the conserved Vif F1-, F2-, and F3-box motifs are essential for both A3C and A3F degradation, and an additional four residues are uniquely required for A3F degradation. Modeling of the Vif structure on an HIV-1 Vif crystal structure revealed that three discontinuous flexible loops of Vif F1-, F2-, and F3-box motifs sterically cluster to form a flexible A3F interaction interface, which represents hydrophobic and positively charged surfaces. We found that the basic Vif interface patch (R17, E171, and R173) involved in the interactions with A3C and A3F differs. Furthermore, our crystal structure determination and extensive mutational analysis of the A3F C-terminal domain demonstrated that the A3F interface includes a unique acidic stretch (L291, A292, R293, and E324) crucial for Vif interaction, suggesting additional electrostatic complementarity to the Vif interface compared with the A3C interface. Taken together, these findings provide structural insights into the A3F-Vif interaction mechanism, which will provide an important basis for development of novel anti-HIV-1 drugs using cellular cytidine deaminases.
UR - http://www.scopus.com/inward/record.url?scp=84954176012&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84954176012&partnerID=8YFLogxK
U2 - 10.1128/JVI.02369-15
DO - 10.1128/JVI.02369-15
M3 - Article
C2 - 26537685
AN - SCOPUS:84954176012
SN - 0022-538X
VL - 90
SP - 1034
EP - 1047
JO - Journal of Virology
JF - Journal of Virology
IS - 2
ER -